REPORT ID 3215

China Facial Injectables Market Research Report 2017

Publish Date
12-Dec-17
Pages
110
Format
Electronic (PDF)

The global Facial Injectables market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Facial Injectables development status and future trend in China, focuses on top players in China, also splits Facial Injectables by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Allergan
    Prollenium Medical Technologies Inc
    Galderma
    Merz Aesthetics
    Ipsen Group
    Bloomage BioTechnology
    Hangzhou Techderm Biological Products
    Laboratory Obvieline
    Medytox
    Polymekon
    Qufu Guanglong Biochem
    Revitacare
    Suneva Medical
    SciVision Biotech
    Speciality European Pharma
    Syneron
    Visionmed
    AQTIS Medical

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into
    Botulinum Toxin
    Hyaluronic Acid
    Collagen
    Particle & Polymer Fillers (PPF)

On the basis of the end users/application, this report covers
    Hospitals
    Ambulatory Surgical Centers
    Cosmetic Centers
    Dermatology Clinics
    Physician Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Facial Injectables Market Research Report 2017
1 Facial Injectables Overview
    1.1 Product Overview and Scope of Facial Injectables
    1.2 Classification of Facial Injectables by Product Category
        1.2.1 China Facial Injectables Sales (K Doses) Comparison by Type (2012-2022)
        1.2.2 China Facial Injectables Sales (K Doses) Market Share by Type in 2016
        1.2.3 Botulinum Toxin
        1.2.4 Hyaluronic Acid
        1.2.5 Collagen
        1.2.6 Particle & Polymer Fillers (PPF)
    1.3 China Facial Injectables Market by Application/End Users
        1.3.1 China Facial Injectables Sales (K Doses) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Cosmetic Centers
        1.3.5 Dermatology Clinics
        1.3.6 Physician Clinics
    1.4 China Facial Injectables Market by Region
        1.4.1 China Facial Injectables Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Facial Injectables Status and Prospect (2012-2022)
        1.4.3 East China Facial Injectables Status and Prospect (2012-2022)
        1.4.4 Southwest China Facial Injectables Status and Prospect (2012-2022)
        1.4.5 Northeast China Facial Injectables Status and Prospect (2012-2022)
        1.4.6 North China Facial Injectables Status and Prospect (2012-2022)
        1.4.7 Central China Facial Injectables Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Facial Injectables (2012-2022)
        1.5.1 China Facial Injectables Sales (K Doses) and Growth Rate (%)(2012-2022)
        1.5.2 China Facial Injectables Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Facial Injectables Market Competition by Players/Manufacturers
    2.1 China Facial Injectables Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Facial Injectables Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Facial Injectables Average Price (USD/Dose) by Players/Manufacturers (2012-2017)
    2.4 China Facial Injectables Market Competitive Situation and Trends
        2.4.1 China Facial Injectables Market Concentration Rate
        2.4.2 China Facial Injectables Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Facial Injectables Manufacturing Base Distribution, Sales Area, Product Types

3 China Facial Injectables Sales and Revenue by Region (2012-2017)
    3.1 China Facial Injectables Sales (K Doses) and Market Share by Region (2012-2017)
    3.2 China Facial Injectables Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Facial Injectables Price (USD/Dose) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Facial Injectables Sales (K Doses) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Facial Injectables Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Facial Injectables Price (USD/Dose) by Type (2012-2017)
    4.4 China Facial Injectables Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Facial Injectables Sales (K Doses) and Market Share by Application (2012-2017)
    5.2 China Facial Injectables Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Facial Injectables Players/Suppliers Profiles and Sales Data
    6.1 Allergan
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Facial Injectables Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Allergan Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Prollenium Medical Technologies Inc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Facial Injectables Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Prollenium Medical Technologies Inc Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Galderma
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Facial Injectables Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Galderma Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merz Aesthetics
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Facial Injectables Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merz Aesthetics Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Ipsen Group
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Facial Injectables Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Ipsen Group Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Bloomage BioTechnology
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Facial Injectables Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Bloomage BioTechnology Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Hangzhou Techderm Biological Products
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Facial Injectables Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Hangzhou Techderm Biological Products Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Laboratory Obvieline
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Facial Injectables Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Laboratory Obvieline Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Medytox
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Facial Injectables Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Medytox Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Polymekon
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Facial Injectables Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Polymekon Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Qufu Guanglong Biochem
    6.12 Revitacare
    6.13 Suneva Medical
    6.14 SciVision Biotech
    6.15 Speciality European Pharma
    6.16 Syneron
    6.17 Visionmed
    6.18 AQTIS Medical

7 Facial Injectables Manufacturing Cost Analysis
    7.1 Facial Injectables Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Facial Injectables

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Facial Injectables Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Facial Injectables Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Facial Injectables Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Facial Injectables Sales (K Doses), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Facial Injectables Sales (K Doses) Forecast by Type (2017-2022)
    11.3 China Facial Injectables Sales (K Doses) Forecast by Application (2017-2022)
    11.4 China Facial Injectables Sales (K Doses) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List